← Back to Search

Web-based Education for Congenital Heart Disease Transition

N/A

Recruiting

Led By Karen Uzark, PhD, CPNP

Research Sponsored by University of Michigan

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Ages 13-25

Diagnosed with congenital heart disease

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline, 12 months

Awards & highlights

Study Summary

This trial is testing how helpful web-based transition education is for teens and young adults with congenital heart disease as they become adults and leave pediatric care.

Who is the study for?

This trial is for young people aged 13-25 with congenital heart disease who are already seeing a cardiologist regularly. It's not suitable for new patients, those currently dealing with an urgent health issue, non-English speakers, or individuals with severe brain function issues that make it hard to fill out a survey.Check my eligibility

What is being tested?

The study is testing if learning about transitioning from pediatric to adult healthcare through a web-based program can help teens and young adults manage their heart condition better and use health services more effectively.See study design

What are the potential side effects?

Since this intervention involves educational content delivered online, there are no direct medical side effects. However, participants may experience fatigue or eye strain from screen time.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am between 13 and 25 years old.

Select...

I was born with a heart condition.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline, 12 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline, 12 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in transition readiness score, as measured by transition readiness survey

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Web-based Educational InterventionExperimental Treatment1 Intervention

This group of participants will be given access to a web-based educational resource in addition to the standard of care.

Group II: Standard of CareActive Control1 Intervention

This group will be given only the standard of care during their clinic visit.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Web-based Educational Intervention

2011

N/A

~10

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

University of MichiganLead Sponsor

1,794 Previous Clinical Trials

6,373,736 Total Patients Enrolled

Karen Uzark, PhD, CPNPPrincipal Investigator - University of Michigan

University of Michigan

Media Library

Web-based Educational Intervention Clinical Trial Eligibility Overview. Trial Name: NCT03303248 — N/A

Congenital Heart Disease Research Study Groups: Web-based Educational Intervention, Standard of Care

Congenital Heart Disease Clinical Trial 2023: Web-based Educational Intervention Highlights & Side Effects. Trial Name: NCT03303248 — N/A

Web-based Educational Intervention 2023 Treatment Timeline for Medical Study. Trial Name: NCT03303248 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is there still availability for participants in this trial?

"Affirmative, the information on clinicaltrials.gov reveals that this experiment is presently seeking volunteers. It was initially announced August 27th 2018 and its last revision occurred June 22nd 2022. The trial needs to recruit 180 participants from a single facility."

Answered by AI

To whom is participation in this experiment open?

"The criteria for admission to this cardiovascular trial is the presence of a heart disease and an age between 13 and 25. A total of 180 prospective patients are being sought out."

Answered by AI

What is the enrollment rate of individuals participating in this experiment?

"Affirmative. According to clinicaltrials.gov, this clinical trial is actively recruiting volunteers; the original posting was on August 27th 2018 and it has since been updated on June 22nd 2022. The trial requires 180 people from one medical centre for enrolment."

Answered by AI